Search research articles
Contact Us
Filters
Showing results (201-210 of 377) with videos related to
Page
of 38
Sort By:
Journal of Thoracic Imaging
|
May 16, 2022
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography
Claudia Roncella, Simone Barsotti, Adele Valentini, et al.
Inflammopharmacology
|
August 3, 2023
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
Marco Di Battista, Laura Tavanti, Francesco Pistelli, et al.
Rheumatology (Oxford, England)
|
March 21, 2026
Exploring sleep health and circadian rhythm disruption in Sjögren's disease: an accelerometric and self-reported cross-sectional study
Caterina Di Pede, Alessandro Colitta, Simone Bruno, et al.
Lupus Science & Medicine
|
July 23, 2024
When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus
Chiara Tani, Michele Maffi, Giancarlo Cascarano, et al.
Clinical Rheumatology
|
December 22, 2023
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy
Francesco D'Alessandro, Massimiliano Cazzato, Elenia Laurino, et al.
Rheumatology (Oxford, England)
|
April 24, 2023
Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches
Michele Maffi, Chiara Tani, Giancarlo Cascarano, et al.
Seminars in Arthritis and Rheumatism
|
April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Clinical and Experimental Rheumatology
|
August 24, 2020
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
Irma Convertino, Ersilia Lucenteforte, Rosa Gini, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 28, 2025
Effectiveness of Plastic Stent for the Treatment of Incomplete Clearance of Common Bile Duct Stone: A Systematic Review and Meta-analysis
Marco Valvano, Antonio Vinci, Filippo Antonini, et al.
Joint Bone Spine
|
June 26, 2025
Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis
Marco Di Battista, Chiara Romei, Laura Tavanti, et al.
Page
of 38
Search research articles
Search
Showing results (201-210 of 377) with videos related to
Sort By:
Page
of 38
Journal of Thoracic Imaging
|
May 16, 2022
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography
Claudia Roncella, Simone Barsotti, Adele Valentini, et al.
Inflammopharmacology
|
August 3, 2023
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
Marco Di Battista, Laura Tavanti, Francesco Pistelli, et al.
Rheumatology (Oxford, England)
|
March 21, 2026
Exploring sleep health and circadian rhythm disruption in Sjögren's disease: an accelerometric and self-reported cross-sectional study
Caterina Di Pede, Alessandro Colitta, Simone Bruno, et al.
Lupus Science & Medicine
|
July 23, 2024
When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus
Chiara Tani, Michele Maffi, Giancarlo Cascarano, et al.
Clinical Rheumatology
|
December 22, 2023
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy
Francesco D'Alessandro, Massimiliano Cazzato, Elenia Laurino, et al.
Rheumatology (Oxford, England)
|
April 24, 2023
Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches
Michele Maffi, Chiara Tani, Giancarlo Cascarano, et al.
Seminars in Arthritis and Rheumatism
|
April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Clinical and Experimental Rheumatology
|
August 24, 2020
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
Irma Convertino, Ersilia Lucenteforte, Rosa Gini, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 28, 2025
Effectiveness of Plastic Stent for the Treatment of Incomplete Clearance of Common Bile Duct Stone: A Systematic Review and Meta-analysis
Marco Valvano, Antonio Vinci, Filippo Antonini, et al.
Joint Bone Spine
|
June 26, 2025
Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis
Marco Di Battista, Chiara Romei, Laura Tavanti, et al.
Page
of 38